• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下议院委员会发布关于加拿大毒品战略的报告。

House of Commons committee releases report on Canada's drug strategy.

作者信息

Jürgens Ralf

出版信息

Can HIV AIDS Policy Law Rev. 2002 Dec;7(2-3):9-12.

PMID:14719486
Abstract

On 17 May 2001, the House of Commons created a Special Committee on Non-Medical Use of Drugs based on a motion introduced by Randy White, Canadian Alliance MP (Langley-Abbottsford) and gave it a very broad mandate to study "the factors underlying or relating to the non-medical use of drugs in Canada" and to propose recommendations aimed at reducing "the dimensions of the problem involved in such use." In December 2002, the Committee released its report, entitled Policy for the New Millennium: Working Together to Redefine Canada's Drug Strategy. The report contains many good recommendations, but fails to deal adequately with the fundamental harms caused by Canada's drug laws and federal government inaction. Far better is the supplementary report written by NDP MP Libby Davies (Vancouver East), which contains an excellent, informed critique of the report. The supplementary report from the official opposition, written by MPs Randy White and Kevin Sorenson (Crowfoot, Alberta) also makes for interesting, if troubling, reading--it is based nearly exclusively on fiction rather than facts and science.

摘要

2001年5月17日,下议院根据加拿大联盟党议员兰迪·怀特(兰利-阿伯茨福德选区)提出的议案,成立了一个关于药物非医疗用途的特别委员会,并赋予其广泛的任务,即研究“加拿大药物非医疗用途的相关因素”,并提出旨在减少“此类用途所涉问题规模”的建议。2002年12月,该委员会发布了其报告,题为《新千年政策:共同努力重新定义加拿大的毒品战略》。该报告包含许多不错的建议,但未能充分应对加拿大毒品法律及联邦政府不作为所造成的根本危害。新民主党议员利比·戴维斯(温哥华东部选区)撰写的补充报告要好得多,其中对该报告进行了出色且有见地的批评。官方反对党议员兰迪·怀特和凯文·索伦森(艾伯塔省克劳福特选区)撰写的补充报告读起来也饶有趣味,尽管令人不安——它几乎完全基于虚构内容,而非事实和科学。

相似文献

1
House of Commons committee releases report on Canada's drug strategy.下议院委员会发布关于加拿大毒品战略的报告。
Can HIV AIDS Policy Law Rev. 2002 Dec;7(2-3):9-12.
2
Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.加拿大卫生部医用大麻政策与实践中的道德规范及有罪推定
Int J Drug Policy. 2009 Jul;20(4):296-303. doi: 10.1016/j.drugpo.2008.09.007. Epub 2009 Jan 4.
3
Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.加拿大四大省份早期大麻监管政策规划:描述性概述。
Subst Use Misuse. 2019;54(10):1691-1704. doi: 10.1080/10826084.2019.1608249. Epub 2019 May 10.
4
The bio-food industry's corporate political activity during Health Canada's revision of Canada's food guide.生物食品行业在加拿大卫生部修订加拿大食物指南期间的企业政治活动。
Health Promot Chronic Dis Prev Can. 2023 Dec;43(12):485-498. doi: 10.24095/hpcdp.43.12.01.
5
Canadian senate committee to review drug laws and policies.
Can HIV AIDS Policy Law Newsl. 2000 Spring-Summer;5(2-3):59-60, 64-5.
6
From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada.从厨师帽到大麻烟:加拿大全国范围内大麻合法化面临的两大挑战。
Int J Drug Policy. 2017 Apr;42:97-101. doi: 10.1016/j.drugpo.2017.03.002. Epub 2017 Apr 1.
7
Canada's 2003 renewed drug strategy--an evidence-based review.加拿大2003年更新的药物战略——基于证据的审查。
HIV AIDS Policy Law Rev. 2006 Dec;11(2-3):1, 5-12.
8
Drug policy in Canada--the way forward.加拿大的毒品政策——前进之路。
Can HIV AIDS Policy Law Rev. 2002 Jul;7(1):1, 27-32.
9
Do provincial drug benefit initiatives create an effective policy lab? The evidence from Canada.省级药品福利计划是否能创造有效的政策实验室?来自加拿大的证据。
J Health Polit Policy Law. 2010 Oct;35(5):705-42. doi: 10.1215/03616878-2010-025.
10
Subcommittee fails to recommend legal reforms needed to promote human rights of sex workers.小组委员会未能推荐促进性工作者人权所需的法律改革。
HIV AIDS Policy Law Rev. 2007 May;12(1):15-7.